Drugs / Derinat
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04149431 Comparator | Dec 2019 → May 2022 | respiratory tract infectious disorder | PharmPak, LLC | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Derinat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04149431 ↗ |
| Route | Intranasal | “nasal drops” NCT04149431 ↗ |